Editorial

Meet the team


Family Practice - a global perspective

The status of health and medicine in the Middle East - disease control


Histopathological relationship between severity of inflammatory reaction in gastritis and intensity of Helicobacter pylori in the antrum

Hypospadias: does the usage of Clomiphene citrate influence the incidence

Level of Hemoglobins in Sickle Cell Trait in Basrah using HPLC


Assure Safer Drug Therapy in the Middle East


An Investigation of Medical staff awareness of patients’ rights in Fasa hospitals and Medical centers

The investigation of effective factors on patients’ satisfaction Parent-Adolescent Relationships in the City of Amol


An epidemiological survey on maternal mortality rate and fatcors contributing to maternal mortality in rural area of Peshawar



Microdilution In Vitro Susceptibility Testing of 71 species of Dermatophytes isolated from pediatric cases in Nigeria against five antifungal agents


Development of Encounter Forms for Cardiovascular Disease Risk Management

 


Abdulrazak Abyad
MD, MPH, MBA, AGSF, AFCHSE

Editorial office:
Abyad Medical Center & Middle East Longevity Institute
Azmi Street, Abdo Center,
PO BOX 618
Tripoli, Lebanon

Phone: (961) 6-443684
Fax:     (961) 6-443685
Email:
aabyad@cyberia.net.lb

 
 

Lesley Pocock
medi+WORLD International
572 Burwood Road,
Hawthorn 3122
AUSTRALIA
Emai
l
: lesleypocock

 


Microdilution In Vitro Susceptibility Testing of 71 species of Dermatophytes isolated from pediatric cases in Nigeria against five antifungal agents

 
AUTHOR

Nweze, EI [1,2], Ogbonna, C.C [3], Okafor, JI [1]

  1. Department of Microbiology,
    Univeristy of Nigeria, Nsukka, Nigeria.
  2. Department of Applied Microbiology,
    Ebonyi State University, Abakiliki, Nigeria.
  3. Department of Biochemistry and Biotechnology,
    Ebonyi State University, Abakiliki, Nigeria.

 


ABSTRACT

The antifungal activities of Itraconazole, Ketoconazole, fluconazole, terbinafine and griseofulvin against 71 isolates of dermatophytes belonging to three different species viz: Trichophyton(67), Microsporium(2) and E.Flocossum(2) isolated from children were tested by broth microdilution methods. Most drugs were very active against all the dermatophytes, MIC 90 ranging between 0.03 to 8.0. Thus far, no resistance was recorded, especially among the isolates. This appears to be the first documented data on the susceptibility of isolates of dermatophytes from Nigeria.

Keywords: Antifungal, Microdilution, dermatophytes, Children.

INTRODUCTION

Dermatophytes are communicable fungal disease caused by three genera of fungi namely, Trichophyton, Microsporum and Epidermophyton. Several varieties of tropical and systematic preparation are reported to have reasonable activity in these diseases and are being used in treating these superficial mycotic infections (1,2). Although in the last few years, there has been a steady introduction of new drugs by either modification of pre-existing or entirely new chemical classes of antimycotics, there has also been an increased interest in clinically relevant susceptibility testing (3). This has become necessary due to a considerable increase in the incidence of dermotophytoses all over the world especially in underdeveloped countries such as Nigeria (4-7) among the elderly and in immunocompromised patients.(8). In developed countries of Europe and America and fast developing countries of Asia, data on the antifungal susceptibility of dermatophytes could not be said to be entirely scanty, the case appears different in African countries, such as Nigeria, where unfortunately, the occurrence of dermatophytosis is endemic. Expansion of information on invitro susceptibility testing of dermatophytes will provide data that will help in developing or selecting drug regimens (9). In addition, the various cases of imported dermatophyte infection across different countries and the variability in the antimycotic properties of similar strains obtained across different geographical locations of the world make exchange of information on susceptibility data across different countries necessary. We carried out susceptibility studies on clinical isolates obtained in children previously. We believe that our data will also help clinicians to choose appropriate antifungal agents for a successful treatment outcome in their patients especially in countries like ours where immediate laboratory diagnosis for this infections are not readily performed before treatments are administered.

MATERIALS AND METHODS

Test isolates

Seventy-one isolates of dermatophytes were evaluated. Out of this 27 were Trichophyton tonsurans, 15 were Trichophyton soudanense,7 were Trichophyton violaceum, 5 were Trichophyton rubrum, 4 were Trichophyton verrucosum, 9 were Trichophyton mentagrophytes, 3 were Trichophyton schoenlenii and 2 each of Epidermophyton flocossum and Microsporum audounii. Three American typed culture collections (ATCC) quality control organisms were used: Candida parasilopsis ATCC22019, Trichophyton mentagrophytes (ATCC 40004) and Candida krusei ATCC 6258. These dermatophytes were mainly isolates from different body sites collected from children during previous investigational study. (4,5). The cultures were maintained on Saboraud dextrose agar slants supplemented with cycloheximide, chloramphenicol and genticin (SAB-CCG). Freshly growing cultures on SAB-CCG slants were transferred to oatmeal agar slants two weeks prior to the study to enhance conidial production as proposed previously (10)

Antifungal agents

Five antifungal agents were used, itraconazole (ITR) and ketoconazole (KET) (Jansen), fluconazole (FLU) (Pfizer), terbinafine (TER), (Novartis) and griseofulvin (GRI) (Schering plough). Fluconzole and ketoconazole were dissolved in sterile distilled water while the rest were dissolved in 100% dimethylsulphuroxide (Sigma-Aldrich). They are subsequently prepared as stock solutions and stored at appropriate temperature.

Invitro tests for susceptibility

Drug dilutions/medium: RPMI 1640 (Sigma- Aldrich) with L- glutamine but without sodium bicarbonate and buffered at PH 7 with MOPS was used for susceptibility testing.

Preparation of Inoculums

The method previously described by Norris et al (11) was used. Briefly; conidial suspensions of dermatophytes prepared from seven to fourteen day old culture grown on oatmeal cereal agar slants were made. Cultures producing between fifty and hundred conidia per field of view, for at least five different fields of view, were selected for testing. The selected slants were flooded with 0.85% sterile saline and swabbed with a cotton wool tip applicator. The resulting mixture of conidia and hyphal particles were subsequently transferred to a sterile tube. After settling for about 15-20 minutes, the upper layer (about 2ml) of the suspension was removed and adjusted for 80-85% transmission using a colorimeter. This corresponds to an inoculum of 1-5 x 106 CFU/ml. The inoculum was adjusted to 5ml with saline (0.85%) and diluted further in RPML 1640 to achieve a final concentration of 2-5 x 103 CFU/ml.

 

 

Testing procedure

Following CLSI guidelines M 27-P (12), Micro dilution plates were set up. Each test plate had two drug free growth controls, one with the media alone (growth control) and the other with media containing an equivalent amount of solvent used to dissolve the antifungal drug (solvent control). The plates (two for each) were incubated at 300c and 350c respectively and read visually after 4 and 5 days of incubation. Growth was normally checked after 48hrs post inoculation. Endpoint determinations were made by visually comparing the growth in the wells containing the drug with the growth in the solvent control well. MIC ranges were obtained for each species-drugs combination tested. To facilitate comparisons of the activities of the drugs, the MIC were reported as the concentration at which 50% (MIC50) and 90% (MIC90) of the isolates were inhibited.

RESULTS

The in vitro susceptibilities of 71 isolates of dermatophytes to terbinafine, itraconazole, ketoconazole, fluconazole and griseofulvin are summarized in Table 1. The data are presented as MIC ranges and, where appropriate, as the drug concentrations required to inhibit 50 and 90% of the isolates of each species (MIC90 and MIC50 respectively). The readings were obtained after 7 days of incubation. All the 71 isolates of dermatophytes tested were susceptible to the five antifungal drugs used in the study. The MIC of all the quality control strains used were within established ranges (data not shown) (13).

Although detectable growths were noticed after four days of incubation in some cases, majority of the isolates had pronounced growth after 5 days. We observed no major differences in incubating at 30 or 350C,but our results reflect readings recorded at 350C. However, no resistance was recorded among all the isolates. The isolates were less susceptible for griseofilvin and fluconazole with MICs ranging from 0.125 - 16.0 and 0.25- 64ug/ml. The MIC90 range for them respectively is between 2.0-8.0 ug/ml for griseofulvin and 4.0-16.0ug/ml for fluconazole. Terbinafine was the most effective drug against all isolates of dermatophytes since the MIC90 range was between 0.01-0.07mg/ml. The order of in vitro activity is therefore terbinafine > itraconazole > ketoconazole > griseofulvin > fluconazole

DISCUSSION

This is the first large -scale in vitro susceptibility testing of dermatophytes obtained from Nigeria against a wide range of commonly used antifungals in our country. Monitoring antimicrobial resistance is useful because apart from tracking and detection of resistance trends by microorganisms, it is also gives clues to emerging threats of new resistance. This serves among other things, in assessing interventional efforts and empirical treatments recommendations (14). In the past, several authors have performed in vitro susceptibility tests on various strains of dermatophytes (8, 10,11). However, there appears to be a lack of data on susceptibility studies of isolates from the West African sub region like Nigeria where this infection is endemic (4-5). We observed no major differences in the MIC endpoints by incubating at 300c or 350c. Information available in the literature from other authors (10, 15, 16) indicated that 4 days of incubation was sufficient to observe noticeable growth in the control wells. Our findings are also in agreement. We therefore recorded our MIC values after 4 days of incubation. However, studies from Santos and Hamden (17) and fromBelkys. Fernandez-Torres et al (18) are not in similar agreement. In another study by Fernadez-Torres and co-workers (19), 508 strains belonging to 24 species of dermatophytes were tested against conventional (itraconazole and fluconazole) and some newer antifungal agents like voriconazole and UR-9825. Our results on itraconazole and fluconazole are similar to those in their study. This tends to support the fact that incubating after 4 or 7 days does not have a significant impact on the MIC readings. Nevertheless, our result on terbinafine as the most active agent for example, agrees with the observation from previous authors in other continents and region (17,18). This antimycotic showed an excellent in vitro potency and broad-spectrum activity against all the tested species. This suggests that terbinafine can be used to treat a majority of dermatophytic infections especially those showing high MIC values on the azoles, such as fluconazole. Although we did not include the newer antifungals such as posaconzole, voriconazole etc in our study, we noticed in literature, their promising antifungal activities. In Nigeria, these antifungal are relatively new and not readily available, affordable and widely used as the ones we have tested. This buttresses our initial observation that most patients with dermatophytoses resort to use of some medicinal plants as a preferred treatment choice apparently due to inability to afford the orthodox drugs (4). It will be of interest to state that all isolates used in our study were obtained from patients not previously on any antifungal treatment. Interestingly; there was no record of resistance in our study even though some agents recorded high MIC values than others. From our data, ketoconazole appears to be next choice in terms of in vitro activity after terbinafine and itraconazole. This information among other things will assist clinicians to monitor trend and be able to choose effective medications for treating patients with dermatophytoses, especially in countries like Nigeria where dermatophytoses have become a public health problem and have remained endemic (5).

 

 

Table 1. MICs of the five drugs against seventy-one clinical isolates of dermotophytes. MIC (ug/mL)

Species (nA) Antifungal Drug Range MIC50B MIC90
T. tonsurans(25) TER 0.007-0.125 0.07 0.125
  ITR 0.06-0.5000 0.01 0.03
  KET 0.125-1.00 0.125 0.25
  FLU 0.25-16.00 1.00 4.00
  GRI 0.50-16.00 2.00 8.00
T. soundanense TER 0.01-0.25 0.01 0.06
  ITR 0.03-0.125 0.03 0.125
  KET 1.00-16.00 1.00 2.00
  FLU 8.00-32.00 8.00 16.00
  GRI 2.00-16.00 2.00 8.00
T.mentagrophytes (9) TER 0.007-0.500 0.07 0.07
  ITR 0.01-4.00 0.01 0.50
  KET 0.06-4.00 0.05 1.00
  FLU 0.06-64.00 2.00 4.00
  GRI 0.125-4.00 0.50 2.00
T.violaceum (7) TER 0.007-0.125 0.01 0.0125
  ITR 0.01-1.00 0.01 1.00
  KET 0.03-0.25 0.25 8.00
  FLU 1.00-8.00 1.00 8.00
  GRI 0.25-8.00 0.50 4.00
T.verrucosum(4) TER 0.007-0.125 0.007 0.0125
  ITR 0.125-1.00 0.125 1.00
  KET 1.00-16.00 2.00 8.00
  FLU 4.00-16.00 4.00 8.00
  GRI 0.50-4.00 4.00 4.00
T.rubrum(5) TER 0.03-0.25 0.007 0.01
  ITR 0.03-1.00 0.03 0.25
  KET 0.125-4.00 0.125 0.50
  FLU 1.00-8.00 2.00 4.00
T.schoeinlenii(3) TER 0.007 - -
  ITR 0.01-0.50 - -
  KET 0.06-0.125 - -
  FLU >16 - -
  GRI 4.00-16.00 - -
M.audouinii(2) TER 0.01 - -
  ITR 0.01-0.125 - -
  KET 0.01-0.50 - -
  FLU 0.50-2.00 - -
  GRI 0.25-1.00 - -
E.flocossum TER 0.01-0.125 - -
  ITR 0.01-0.50 - -
  KET 0.01-1.00 - -
  FLU 0.50-2.00 - -
  GRI 1.00-2.00 - -

nA, number of isolates tested.
B, MIC for 50% of the isolates tested.
-, MIC 50 and 90 were not determined because of thr small sample number.

 


REFERENCES
1. Roberts DT. Onychomycosis:current treatment and future challenges.Br J Dermatol 1999; 141:1-4.
2. Gupta AK, Del Rosso JQ.An evaluation of intermittent therapies used to treat onychomycosis and other dermatomycoses with the oral antifungal agents.Int J Dermatol 2000; 39:401-411.
3. Rex JH, Pfaller MA, Walsh TJ, et al Antifungal susceptibility testing: practical aspects and current challenges.Clin Microbiol Rev 2001;14: 643-658.
4. Nweze EI, Okafor JI. Prevalence of dermatophytic fungal infections in children: A recent study in Anambra state, Nigeria. Mycopathologia. 2005. 160: 239-243.
5. Nweze EI Etiology of dermatophytoses amongst children in northeastern Nigeria. Medical mycology 2001. 39: 181-184.
6. Gugnani HC, Njoku-Obi ANU. Tinea capitis in school children in eastern Nigeria. Mycosen 1986: 29: 132-144
7. Ekanem LS, Gugnani HC. Etiology of dermatophytoses in cross-River state of Nigeria. Mykosen 1987; 30: 493-498.
8. Belkys Fernandez-Torres, Isabel Inza, and Joseph Guarro. In vitro activities of the new antifungal agents against 200 strains of dermatophytes. J.Clin. Microbial 2003.41, 5209-5211.
9. Gupta AK, Kohli Y and Batra R. In vitro activities of posaconazole, ravuconazole, terbinafine, itraconazole and fluconazole against dermatophyte,yeast and non-dermatophyte species.Medical Mycology 2005;43:179-185
10. Norris H.A., B. Elewski, and M.A Ghannoum. Optimal growth fir the determination of the antifungal susceptibility of the three species of dermatophytes with use of the micro dilution method.J.Am.Aca.Dermatol. 1999 40: S9-S13.
 
11. National committee for clinical laboratory standards. Reference method for broth dilution antifungal susceptibility testing of conidium- forming filamentous fungi. Proposed standard; document no. M38-P.Wayne, PA: NCCLS, 1998.
12. Barry, A.L, M.A Pfaller, S.D Brown, et al. Quality control limits of broth micro dilution susceptibility tests of ten antifungal agents., J.Clin,Microbiol.2000 33: 3457-3459.
13. M.A Pfaller, D.J Diekema, S.A Messer, et al. Activities of fluconazole and voriconazole against 1,586 recent clinical isolates of candida species determined by broth microdilution, disk diffusion, and Etest methods: Report from the ARTEMIS global antifungal susceptibility program, 2001.J.Clin Microbiol. 2003 41: 1440-1446
14. Ghannoum MA, Chaturvedi V, Espinel-Ingroff A, M.A Pfaller, M.G.Rinaldi, W.Lee-yang, and D.W Warnock.Intra- and Interlaboratory study of a method for testing the antifungal susceptibilities of Dermatophytes.J.Clin.Microbiol.2004 42: 2977-2979
15. Favre, B.B.Hofbauer, H, Kwang-soo and N.S Ryder. Comparism of in vitro activities of 17 antifungal drugs against a panel of 20 dermatophytes by using micro dilution assay.J.Clin. Microbiol. 2003:4817-4819.
16. D.A Santos and J.S Hamada Evaluation of broth micro dilution antifungal susceptibility testing conditions for Trichophyton rubrum.J.Clin.Microbiol.2005.43: 1917-1920
17. Belkys.Fernandez-Torres, Francisco .J. Cabanes, Alfonso J, et al Collaborative Evaluation of optimal susceptibility testing condition for dermatophytes. J.Clin. Microbiol. 2002 40: 3999-4003.
18. Fernadez-Torres B, Carrillo ME, Del Palacio A et al In vitro activities of 10 antifungal drugs against 508 dermatophytes strains.Antimicrob Agents Chemother 2001;45:2524-2528.